NCATS

The National Center for Advancing Translational Sciences, or NCATS, is a center within the National Institutes of Health (NIH) in the United States. Its primary mission is to catalyze the translation of scientific discoveries into new therapies for patients. NCATS focuses on addressing bottlenecks in the drug development process and developing innovative approaches to research.

Established in 2011, NCATS was formed by merging the former NIH Roadmap Molecular Libraries Initiative and the Clinical and Translational Science Awards (CTSA) Program. The center supports a wide range of research activities, from basic science to clinical trials. Key areas of focus include rare diseases, drug repurposing, and the development of new technologies and methodologies for drug discovery.

NCATS plays a crucial role in fostering collaboration among researchers from academia, industry, and government. It aims to accelerate the journey of promising scientific findings from the laboratory bench to the patient's bedside. The center supports various programs and initiatives designed to overcome challenges in understanding diseases and developing effective treatments. By investing in innovative research and infrastructure, NCATS seeks to improve public health and bring new medical solutions to those in need.